|
🐜
|
Definitions and diagnosis of pulmonary hypertension.
12 auth.
M. Hoeper,
H. Bogaard,
R. Condliffe,
R. Frantz,
D. Khanna,
M. Kurzyna,
...
D. Langleben,
A. Manes,
T. Satoh,
F. Torres,
M. Wilkins,
D. Badesch
|
10 |
2013 |
10
🐜
|
|
🐜
|
Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing.
8 auth.
S. Miyamoto,
N. Nagaya,
T. Satoh,
S. Kyotani,
F. Sakamaki,
M. Fujita,
...
N. Nakanishi,
K. Miyatake
|
10 |
2000 |
10
🐜
|
|
🐜
|
Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension.
12 auth.
N. Nagaya,
T. Nishikimi,
M. Uematsu,
T. Satoh,
S. Kyotani,
F. Sakamaki,
...
M. Kakishita,
K. Fukushima,
Y. Okano,
N. Nakanishi,
K. Miyatake,
K. Kangawa
|
9 |
2000 |
9
🐜
|
|
🐜
|
Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension.
14 auth.
N. Nagaya,
T. Nishikimi,
Y. Okano,
M. Uematsu,
T. Satoh,
S. Kyotani,
S. Kuribayashi,
S. Hamada,
M. Kakishita,
N. Nakanishi,
...
M. Takamiya,
T. Kunieda,
H. Matsuo,
K. Kangawa
|
9 |
1998 |
9
🐜
|
|
🐜
|
Imatinib Mesylate as Add-on Therapy for Pulmonary Arterial Hypertension: Results of the Randomized IMPRES Study
19 auth.
M. Hoeper,
R. Barst,
R. Bourge,
J. Feldman,
A. Frost,
N. Galiè,
M. Gómez-Sánchez,
F. Grimminger,
E. Grünig,
P. Hassoun,
...
N. Morrell,
A. Peacock,
T. Satoh,
G. Simonneau,
V. Tapson,
F. Torres,
D. Lawrence,
D. Quinn,
H. Ghofrani
|
8 |
2013 |
8
🐜
|
|
🐢
|
Percutaneous Transluminal Pulmonary Angioplasty for the Treatment of Chronic Thromboembolic Pulmonary Hypertension
11 auth.
M. Kataoka,
T. Inami,
K. Hayashida,
Nobuhiko Shimura,
H. Ishiguro,
T. Abe,
...
Yuichi Tamura,
M. Ando,
K. Fukuda,
H. Yoshino,
T. Satoh
|
8 |
2012 |
8
🐢
|
|
🐜
|
BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis
29 auth.
Jonathan D. W. Evans,
B. Girerd,
D. Montani,
Xiao-jian Wang,
N. Galiè,
E. Austin,
G. Elliott,
K. Asano,
E. Grünig,
Yi Yan,
Z. Jing,
A. Manes,
M. Palazzini,
L. Wheeler,
Ikue Nakayama,
...
T. Satoh,
C. Eichstaedt,
K. Hinderhofer,
M. Wolf,
E. Rosenzweig,
W. Chung,
F. Soubrier,
G. Simonneau,
O. Sitbon,
S. Gräf,
S. Kaptoge,
E. di Angelantonio,
M. Humbert,
N. Morrell
|
8 |
2016 |
8
🐜
|
|
🐜
|
Serum uric acid levels correlate with the severity and the mortality of primary pulmonary hypertension.
9 auth.
N. Nagaya,
M. Uematsu,
T. Satoh,
S. Kyotani,
F. Sakamaki,
N. Nakanishi,
...
M. Yamagishi,
T. Kunieda,
K. Miyatake
|
8 |
1999 |
8
🐜
|
|
🐜
|
Diagnosis of pulmonary hypertension
10 auth.
A. Frost,
D. Badesch,
J. Gibbs,
D. Gopalan,
D. Khanna,
A. Manes,
...
R. Oudiz,
T. Satoh,
F. Torres,
A. Torbicki
|
7 |
2019 |
7
🐜
|
|
🐜
|
Hemodynamic, renal, and hormonal effects of adrenomedullin infusion in patients with congestive heart failure.
13 auth.
N. Nagaya,
T. Satoh,
T. Nishikimi,
M. Uematsu,
S. Furuichi,
F. Sakamaki,
H. Oya,
S. Kyotani,
N. Nakanishi,
Y. Goto,
...
Y. Masuda,
K. Miyatake,
K. Kangawa
|
7 |
2000 |
7
🐜
|
|
🐜
|
Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: Results of a Multicenter Registry
16 auth.
A. Ogawa,
T. Satoh,
T. Fukuda,
K. Sugimura,
Y. Fukumoto,
N. Emoto,
N. Yamada,
A. Yao,
M. Ando,
H. Ogino,
...
N. Tanabe,
I. Tsujino,
M. Hanaoka,
K. Minatoya,
Hiroshi Ito,
H. Matsubara
|
7 |
2017 |
7
🐜
|
|
🐜
|
Effect of orally active prostacyclin analogue on survival of outpatients with primary pulmonary hypertension.
9 auth.
N. Nagaya,
M. Uematsu,
Y. Okano,
T. Satoh,
S. Kyotani,
F. Sakamaki,
...
N. Nakanishi,
K. Miyatake,
T. Kunieda
|
7 |
1999 |
7
🐜
|
